Myotonic dystrophy and heart disease. Behavior of arrhythmic events and conduction disturbances;Distrofia miotônica e cardiopatia: Comportamento dos eventos arrítmicos e dos distúrbios da condução

Arquivos Brasileiros de Cardiologia

Volumn 84, Issue 4, 2005, Pages 330-336

  Nishioka, Silvana Angelina D'Orio ^a,b   Martinelli Filho, Martino ^a   Marie, Suely ^a   Zatz, Mayana ^a   Costa, Roberto ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

Arrhythmias; Cardiac conduction system; Mortality; Myotonic dystrophy

Indexed keywords

ADULT; AGE; ARTICLE; CLINICAL EXAMINATION; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ELECTROCARDIOGRAPHY MONITORING; ELECTROPHYSIOLOGY; FEMALE; FOLLOW UP; GENETIC DISORDER; HEART ATRIUM FLUTTER; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE CONDUCTION DISTURBANCE; HIGH RISK POPULATION; HOLTER MONITORING; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYOTONIC DYSTROPHY; PR INTERVAL; QRS COMPLEX; RISK FACTOR; SUDDEN DEATH; SUPRAVENTRICULAR TACHYCARDIA;

EID: 18844410516     PISSN: 0066782X     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0066-782x2005000400011     Document Type: Article

References (36)

1. Batten FE, Gibb HP. Myotonia atrophica. Brain 1909;32:187-205.
2. Steinert H. Myopathologische Beitäge: uber das klinische und anatomische bild des muskelschwundsder myotoniker. Deutsch Z Nervenheilk 1909;37:58-104.
3. nd edn. W.B. Saunders Co., London, Philadelphia, Toronto, Sydney, Tokyo; 1989:13-36.
4. Wallon JN, Gardner-Medwin D. Progressive muscular dystrophy and myotonic disorders. In. WALTON, Disorders of voluntary muscle (Livingstone, London), 1981.
5. Brook JD, McCurrach ME, Harley HG et al. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeal at 3′ end of a transcript encoding a protein kinasefamily member. Cell 1992;68:799-808.
6. Church S. The heart in myotonia atrophica. Arch Intern Med. 1967; 119, 176-81.
7. Phillips MF, Harper PS. Cardiac disease in myotonic dystrophy. Cardiovasc Res 1997;33:13-22.
8. Cohen MB, Snow J, Merkatz KA et al. Supression of ventricular tachycardia by sotalol in myotonic dystrophy. Am Heart J1996;132:446-9.
9. Hartwing GB, Rao KR, Radoff FM et al. Radionuclide angiocardiographic analysis of myocardial function in myotonic muscular dystrophy. Neurology 1983;33:657-60.
10. th ed Boston, Little, Brown and co. 1964; 114.
11. Hinkle LE Jr, Thaler HT. Clinical classification of cardiac deaths. Circulation 1982; 65: 457-64.
12. Kuller LH. Sudden Death: definition and epidemiologic considerations. Prog Cardiovasc Dis 1980. Supplement 1;23:1-12.
13. Hiromasa S, Ikeda T, Kubota K et al. Ventricular tachycardica and sudden death in myotonic dystrophy. Am Heart J 1988;115:914-15.
14. Komajda M, Frnak R, Vedel J et al. Intracardiac conduction defects in dystrophia myotonica. Br Heart J 1980;43:315-24.
15. Lazarus A, Varin J, Ounnoushene Z et al. Relationships among electrophysiologic findings and clinical status, heart function, and extent of DNA mutation in myotonic dystrophy. Circulation 1999;99:1041-46.
16. Melacini P, Villanova C, Menegazzo E et al. Correlation between cardiac involvement and CTG trinucleolide repeat length in myotonic dystrophy. J Am Coll Cardiol 1995;25:239-45.
17. Motta J, Guilleminault C, Billingham M et al. Cardiac abnormalities in myotonic dystrophy: electrophysiologic and histopathologic studies. Am J Med 1979;67:467-73.
18. Nguyen HH, Wolfe JT, Holmer DR Jr et al. Pathology of the cardiac conduction system in myotonic dystrophy: a sludy of 12 cases. J Am Coll Cardiol 1988; 11:662-71.
19. Pencic-Popovic B, Nagulic S, Cebasek R et al. Arrhythmias conduction defects in myotonic dystrophy. (Ambulatory Electrocardiographic Monitoring Study). Acta Cardiomiol 1992;6:119-26.
20. Perloff JK, Stevenson WG, Roberts NK et al. Cardiac disease in myotonic dystrophy (Steinert's disease): a prospective study of 25 patients. Am J Cardiol 1984; 54: 1074-81.
21. Prystowsky EN, Pritchett ELC, Roses AD et al. The natural history of conduction system disease in myotonic muscular dystrophy as determined by serial electrophysiologic study. Circulation 1979;60:1360-64.
22. Fragola PV, Luzi M, Calo L et al. Cardiac involvement in myotonic dystrophy. Am J Cardiol 1994;74:1070-72.
23. Farah SB. DNA segredos e mistérios. Sāo Paulo; Sarvier, 1997.
24. Howeler CJ, Busch HF, Geraedts JP et al. Anticipation in myotonic dystrophy: fact or fiction? Brain 1989;112:779-97.
25. Zatz M, Passos-Bueno MR, Cerqueira A et al. Analysis of CTG repeat in skeletal muscle of myotonic dystrophy young and adult patients: when does the expansion occur? Hum Molec Genet 1995;4:401-6.
26. Badano L, Autoro C, Fragola P et al. Left ventricular myocardial function in myotonic dystrophy. Am J Cardiol 1993;71:987-91.
27. Gottdiener JS, Hawley RJ, Gay JA et al. Left ventricular relaxation, mitral valve prolapse and intracardiac conduction in myotonia atrophica: assessment by digitized echocardiography and noninvasive His bundle recording. Am Heart J 1982;104:77-85.
28. Moffa PF, Sanches PCR. O eletrocardiograma normal. In. Moffa PF, Sanches PCR. Eletrocardiograma Normal e Patológico. Roca 2001; 99-126.
29. Venco A, Saviotti M, Besana D et al. Noninvasive assessment of left ventricular function in myotonic muscular dystrophy. Br Heart J 1978;40:1262-66.
30. Grigg LE, Chan W et al. Ventricular tachycardia and sudden death in myotonic dystrophy: clinical, electrophysiologic and pathologic features. J Am Coll Cardiol 1985; 6: 254-58.
31. Merino JL, Carmona JR, Fernandez-Lozano I et al. Mechanisms of sustained ventricular tachycardia in myotonic dystrophy: implications for catheter ablation. Circulation 1998; 98:541-6.
32. Colleran JA, Hawley RJ, Pinnow EE et al. Value of the electrocardiogram in determining cardiac events and mortality in myotonic dystrophy. Am J Cardiol 1997;80: 1494-7.
33. Moorman JR, Coleman RE, Packer DL et al. Cardiac involvement in myotonic muscular dystrophy. Medicine 1985;64:371-87.
34. Andrade JCS, Ávila Neto V, Braile DM et al. Diretrizes para o Implante de Marcapasso Cardíaco Permanente: Consenso DECA/SBCCV. Arq Bras Cardiol 1999; 74: 475-80.
35. Babuty D, Fauchier L, Tena-Carbi D et al. Is it possible to identify infrahissian cardiac conduction abnormalities in myotonic dystrophy by non-invasive methods. Heart 1999; 82:634-7.
36. Gregoratos GMFC, Cheitlin MD, Conill A et al. ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmia devices. Circulation 1998; 97: 1325-35.